S1329 Effects of Mirikizumab versus Placebo on Histologic Inflammation Evaluated by Comprehensive Assessment in 5 Intestinal Segments in a Randomized, Controlled Phase 3 Trial of Participants With Crohn’s Disease
American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S952-S953
S1330 Effects of Mirikizumab and Ustekinumab on Histologic Inflammation Evaluated by Comprehensive Assessment in 5 Intestinal Segments in a Randomized Controlled Phase 3 Trial of Participants With Crohn’s Disease
American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S953-S953